Nurchi Valeria M, Crisponi Guido, Pivetta Tiziana, Donatoni Martina, Remelli Maurizio
Dipartimento di Scienze Chimiche, Università di Cagliari, Cittadella Universitaria di Monserrato, 09042 Monserrato-Cagliari, Italy.
J Inorg Biochem. 2008 Apr;102(4):684-92. doi: 10.1016/j.jinorgbio.2007.10.012. Epub 2007 Oct 30.
The iron(III)-1,2-dimethyl-3-hydroxy-4-pyridinone (Deferiprone) system is carefully characterized by a combined potentiometric-spectrophotometric procedure at 25 and 37 degrees C at different ionic strengths, and by thermochemical and quantum-chemical studies. The main purpose of this work was to determine how the temperature dependence of both complex-formation and protonation constants can affect the pFe values on going from 25 degrees C (pFe is normally calculated using 25 degrees C stability constants) to the physiological temperature of 37 degrees C at which chelating agents are active in vivo. The copper(II)-Deferiprone system is also studied and the iron(III)-Deferiprone distribution diagrams in presence of variable copper(II) amounts are shown so as to explain possible side effects due to a competing metal ion during the chelating therapy of iron overload.
采用电位-分光光度联合法,在25℃和37℃、不同离子强度条件下,对铁(III)-1,2-二甲基-3-羟基-4-吡啶酮(去铁酮)体系进行了详细表征,并开展了热化学和量子化学研究。这项工作的主要目的是确定,从25℃(pFe通常使用25℃时的稳定常数计算)到37℃生理温度(螯合剂在体内发挥作用的温度),配合物形成常数和质子化常数对温度的依赖性如何影响pFe值。还对铜(II)-去铁酮体系进行了研究,并给出了存在不同量铜(II)时铁(III)-去铁酮的分布图谱,以解释在铁过载螯合治疗过程中,竞争性金属离子可能产生的副作用。